BioSpace45m
Trump Threatens Big Pharma With Tariffs—Unless They Reshore Manufacturing: Bloomberg
President Trump also refused to promise pharma execs that he would hamstring the IRA’s drug negotiation program.
BioSpace2h
Mirum Establishes Liver Expertise With First FDA Nod for ‘Very Rare’ Disease
Ctexli’s approval further entrenches Mirum as a leader in rare liver diseases, alongside its cornerstone product Livmarli and ...
BioSpace2hOpinion
Opinion: AI Is Pushing the I&I Pendulum From Biologics to Small Molecules
Drug development powered by artificial intelligence is countering incentives from the Inflation Reduction Act and making ...
BioSpace2h
FDA to Rehire Scientists After Trump’s Firing Spree: Reuters
Around 300 FDA staffers laid off last week are being asked to return. So far, the Trump administration has terminated some ...
BioSpace10h
Vertex’s Journavx Changes the Pain Treatment Landscape But Opioids Here to Stay
Non-opioid pain therapies are entering an unprecedented era, marked by the landmark FDA approval of Vertex’s Journavx and a ...
BioSpace10h
RNA Editing Hits the Clinic, Fueling New Hope for Rare and Common Diseases
With the modality now in early clinical trials, experts say more efficiency, broader editing capabilities and delivery ...